TCL Archive Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories” October 24, 2014
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012